Staphyloxanthin: a potential target for antivirulence therapy

Staphyloxanthin: a potential target for antivirulence therapy

Lijun Xue,1,2 Yang Yizhi Chen,1 Zhiyun Yan,3 Wei Lu,1 Dong Wan,4 Huifeng Zhu11College of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing 400715, People’s Republic of China; 2College of Pharmaceutical Engineering, Chongqing Chemical Industr...

Full description

Bibliographic Details
Main Authors:	Xue L, Chen YY, Yan Z, Lu W, Wan D, Zhu H
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-07-01
Series:	Infection and Drug Resistance
Subjects:	staphyloxanthin target antiinfective drug antivirulence therapy
Online Access:	https://www.dovepress.com/staphyloxanthin-a-potential-target-for-antivirulence-therapy-peer-reviewed-article-IDR

Similar Items

Editorial: Antivirulence Drugs Against Bacterial Infections
by: Francesco Imperi, et al.
Published: (2021-05-01)

Photolysis of Staphyloxanthin in Methicillin‐Resistant Staphylococcus aureus Potentiates Killing by Reactive Oxygen Species
by: Pu‐Ting Dong, et al.
Published: (2019-06-01)

Staphyloxanthin inhibitory potential of thymol impairs antioxidant fitness, enhances neutrophil mediated killing and alters membrane fluidity of methicillin resistant Staphylococcus aureus
by: Alaguvel Valliammai, et al.
Published: (2021-09-01)

Factors determining Staphylococcus aureus susceptibility to photoantimicrobial chemotherapy: RsbU activity, staphyloxanthin level and membrane fluidity.
by: Monika Kossakowska-Zwierucho, et al.
Published: (2016-07-01)

Interrelationships between Fatty Acid Composition, Staphyloxanthin Content, Fluidity, and Carbon Flow in the Staphylococcus aureus Membrane
by: Kiran B. Tiwari, et al.
Published: (2018-05-01)

Quorum Quenching Agents: Resources for Antivirulence Therapy
by: Kaihao Tang, et al.
Published: (2014-05-01)

Virulence Determinants Are Required for Brain Abscess Formation Through Staphylococcus aureus Infection and Are Potential Targets of Antivirulence Factor Therapy
by: Ying Zheng, et al.
Published: (2019-04-01)

Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era
by: Nolan Neville, et al.
Published: (2019-01-01)

Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa
by: Francesco Imperi, et al.
Published: (2019-03-01)

Antivirulence and avirulence genes in human pathogenic fungi
by: Sofía Siscar-Lewin, et al.
Published: (2019-01-01)

Uncharted territories in the discovery of antifungal and antivirulence natural products from bacteria
by: Raghav Vij, et al.
Published: (2021-01-01)

Antibiofilm and Antivirulence Activities of 6-Gingerol and 6-Shogaol Against Candida albicans Due to Hyphal Inhibition
by: Jin-Hyung Lee, et al.
Published: (2018-08-01)

Antivirulence effects of pomegranate peel extracts on most common urinary tract infection pathogens in pregnant women
by: Wafaa Sadeq Al-Wazni, et al.
Published: (2016-01-01)

Geraniol as a novel antivirulence agent against bacillary dysentery-causing Shigella sonnei
by: Zainulabedeen R. M. H. Mirza, et al.
Published: (2018-12-01)

Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review
by: Caleb A. Ford, et al.
Published: (2021-01-01)

QseC Inhibition as a Novel Antivirulence Strategy for the Prevention of Acute Hepatopancreatic Necrosis Disease (AHPND)-Causing Vibrio parahaemolyticus
by: Qian Yang, et al.
Published: (2021-01-01)

Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE
by: Valerio Baldelli, et al.
Published: (2020-01-01)

Antibiofilm Activity of Heather and Manuka Honeys and Antivirulence Potential of Some of Their Constituents on the DsbA1 Enzyme of <i>Pseudomonas aeruginosa</i>
by: Oscar Shirlaw, et al.
Published: (2020-12-01)

Identification of Two Depolymerases From Phage IME205 and Their Antivirulent Functions on K47 Capsule of Klebsiella pneumoniae
by: Yannan Liu, et al.
Published: (2020-02-01)

African Plant-Based Natural Products with Antivirulence Activities to the Rescue of Antibiotics
by: Christian Emmanuel Mahavy, et al.
Published: (2020-11-01)

Fluorescence enzymatic assay for bacterial polyphosphate kinase 1 (PPK1) as a platform for screening antivirulence molecules
by: Campos F, et al.
Published: (2019-07-01)

Bifidobacterium mongoliense genome seems particularly adapted to milk oligosaccharide digestion leading to production of antivirulent metabolites
by: Pauline Bondue, et al.
Published: (2020-05-01)

Oligopeptide Targeting Sortase A as Potential Anti-infective Therapy for Staphylococcus aureus
by: Jianfeng Wang, et al.
Published: (2018-02-01)

400-470 NM RADIATION INACTIVATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
by: O. V. Kuzmin, et al.
Published: (2018-02-01)

Staphylococcus aureus pigmentation is not controlled by Hfq
by: Wenfeng Liu, et al.
Published: (2020-02-01)

Antivirulent and antibiofilm salicylidene acylhydrazide complexes in solution and at interfaces
by: Hakobyan, Shoghik
Published: (2015)

ClpP Protease, a Promising Antimicrobial Target
by: Carlos Moreno-Cinos, et al.
Published: (2019-05-01)

Cuminum cyminum L. Essential Oil: A Promising Antibacterial and Antivirulence Agent Against Multidrug-Resistant Staphylococcus aureus
by: Aram Sharifi, et al.
Published: (2021-08-01)

Inhibition of virulence of Staphylococcus aureus – a food borne pathogen – by squalene, a functional lipid
by: B. Sri Charan Bindu, et al.
Published: (2015-10-01)

Effect of low power microwave radiation on pigment production in bacteria
by: Shreya Raval, et al.
Published: (2014-12-01)

Synthesis of novel sulfide-based cyclic peptidomimetic analogues to solonamides
by: José Brango-Vanegas, et al.
Published: (2019-10-01)

Lyophilized Iron Oxide Nanoparticles Encapsulated in Amphotericin B: A Novel Targeted Nano Drug Delivery System for the Treatment of Systemic Fungal Infections
by: Pavan Balabathula, et al.
Published: (2020-03-01)

First investigation of Staphylococcus argenteus in a Brazilian collections of S. aureus isolated from bovine mastitis
by: Bruna F. Rossi, et al.
Published: (2020-07-01)

Photo‐Disassembly of Membrane Microdomains Revives Conventional Antibiotics against MRSA
by: Jie Hui, et al.
Published: (2020-03-01)

Genetic and Virulent Difference Between Pigmented and Non-pigmented Staphylococcus aureus
by: Jing Zhang, et al.
Published: (2018-04-01)

Antifungal and Antivirulence Activity of Vaginal <i>Lactobacillus</i> Spp. Products against <i>Candida</i> Vaginal Isolates
by: Camilla Itapary dos Santos, et al.
Published: (2019-09-01)

From screen to target: insights and approaches into the development of anti-virulence compounds
by: Katherine SH Beckham, et al.
Published: (2014-09-01)

Antibiofilm Activity of Phorbaketals from the Marine Sponge <i>Phorbas</i> sp. against <i>Staphylococcus aureus</i>
by: Yong-Guy Kim, et al.
Published: (2021-05-01)

Global Transcriptomic Analysis of the Candida albicans Response to Treatment with a Novel Inhibitor of Filamentation
by: Jesus A. Romo, et al.
Published: (2019-09-01)

Stable Neutralization of a Virulence Factor in Bacteria Using Temperate Phage in the Mammalian Gut
by: Bryan B. Hsu, et al.
Published: (2020-01-01)